$SCTX SEC Filings

Filed On	Filing
02 Sep 2026	10-Q
02 Sep 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	SCHEDULE 13G
30 Jul 2026	SCHEDULE 13D
30 Jul 2026	SCHEDULE 13D
29 Jul 2026	Form 4: Ah Bio Fund II, L.p., 10% owner and 5 others Received 2,749,392 shares by conversion · Bought 333,333 shares ($5M)
29 Jul 2026	Form 4: Gordon Carl L, Director Received 348,825 shares by conversion · Bought 1,000,000 shares ($15M)
29 Jul 2026	Form 4: Orbimed Advisors Llc, Director and 1 other Received 348,825 shares by conversion · Bought 1,000,000 shares ($15M)
29 Jul 2026	SCHEDULE 13D
29 Jul 2026	Form 4: Doudna Jennifer A, 10% owner Received 12,511 shares by conversion
28 Jul 2026	Form 4: Aghazadeh Behzad, Director and 2 others Bought 2,383,333 shares ($36.1M) · Bought 7,905 shares ($144K)
28 Jul 2026	Form 4: Staahl Brett, 10% owner Granted 4,755 Stock Option (Right to Buy) · Granted 19,385 Stock Option (Right to Buy) · Granted 19,385 Performance-based Stock Option (Right to Buy)
27 Jul 2026	Form 4: Lucas Svetlana, Chief Business Officer Granted 9,547 Stock Option (Right to Buy) · Bought 3,000 shares ($45K) · Granted 109,426 Stock Option (Right to Buy) · 1 more
27 Jul 2026	Form 4: Oakes Benjamin L., Director Granted 12,969 Stock Option (Right to Buy) · Granted 264,784 Stock Option (Right to Buy) · Granted 429,599 Performance-based Stock Option (Right to Buy)
27 Jul 2026	Form 4: Gordon Carl L, Director Granted 14,725 Stock Option (Right to Buy)
27 Jul 2026	Form 4: Watson James Dean, Director Granted 14,725 Stock Option (Right to Buy)
27 Jul 2026	Form 4: Bleharski Joshua, Director Granted 14,725 Stock Option (Right to Buy)
27 Jul 2026	Form 4: Parrot David, Chief Financial Officer Granted 8,909 Stock Option (Right to Buy) · Bought 2,666 shares ($40K) · Granted 109,426 Stock Option (Right to Buy) · 1 more
27 Jul 2026	Form 4: Aghazadeh Behzad, Director and 2 others Granted 14,725 Stock Option (Right to Buy)
27 Jul 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

Comments